These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6574314

  • 1. Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
    Brooke MH, Patterson VH, Kaiser KK.
    Muscle Nerve; 1983; 6(3):204-6. PubMed ID: 6574314
    [Abstract] [Full Text] [Related]

  • 2. Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.
    Sinkeler S, Joosten E, Wevers R, Binkhorst R, Oei L.
    Adv Exp Med Biol; 1986; 195 Pt B():517-23. PubMed ID: 3464164
    [Abstract] [Full Text] [Related]

  • 3. IMP response: an indicator of metabolic stress in working muscle.
    Heller SL, Choksi R, Brooke MH.
    Muscle Nerve; 1986; 9(6):515-8. PubMed ID: 3736584
    [Abstract] [Full Text] [Related]

  • 4. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    Mineo I, Kono N, Shimizu T, Hara N, Yamada Y, Sumi S, Nonaka K, Tarui S.
    J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
    [Abstract] [Full Text] [Related]

  • 5. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I, Kono N, Yamada Y, Hara N, Kiyokawa H, Hamaguchi T, Kawachi M, Yamasaki T, Nakajima H, Kuwajima M.
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [Abstract] [Full Text] [Related]

  • 6. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I, Kono N, Hara N, Shimizu T, Yamada Y, Kawachi M, Kiyokawa H, Wang YL, Tarui S.
    N Engl J Med; 1987 Jul 09; 317(2):75-80. PubMed ID: 3473284
    [Abstract] [Full Text] [Related]

  • 7. Myophosphorylase deficiency impairs muscle oxidative metabolism.
    Haller RG, Lewis SF, Cook JD, Blomqvist CG.
    Ann Neurol; 1985 Feb 09; 17(2):196-9. PubMed ID: 3856415
    [Abstract] [Full Text] [Related]

  • 8. [Myogenic hyperuricemia].
    Yamasaki T, Hamaguchi T, Nakajima H, Matsuzawa Y.
    Nihon Rinsho; 1996 Dec 09; 54(12):3343-8. PubMed ID: 8976117
    [Abstract] [Full Text] [Related]

  • 9. Ischaemic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxanthine.
    Sinkeler SP, Joosten EM, Wevers RA, Binkhorst RA, Oerlemans FT, van Bennekom CA, Coerwinkel MM, Oei TL.
    Clin Sci (Lond); 1986 Apr 09; 70(4):399-401. PubMed ID: 3457669
    [Abstract] [Full Text] [Related]

  • 10. A new variant of late-onset myophosphorylase deficiency.
    Kost GJ, Verity MA.
    Muscle Nerve; 1980 Apr 09; 3(3):195-201. PubMed ID: 6929403
    [Abstract] [Full Text] [Related]

  • 11. ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.
    Bertorini TE, Shively V, Taylor B, Palmieri GM, Fox IH.
    Neurology; 1985 Sep 09; 35(9):1355-7. PubMed ID: 3860749
    [Abstract] [Full Text] [Related]

  • 12. Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
    van Riet W, de Meirsman J, de Saedeleer J, Dom R, Carton H, van den Heede J, Bulcke JA.
    Clin Neurol Neurosurg; 1985 Sep 09; 87(2):85-90. PubMed ID: 3861283
    [Abstract] [Full Text] [Related]

  • 13. Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency.
    Patterson VH, Kaiser KK, Brooke MH.
    Neurology; 1983 Jun 09; 33(6):784-6. PubMed ID: 6682523
    [Abstract] [Full Text] [Related]

  • 14. McArdle disease in a Druze family.
    Sarova-Pinhas I, Sadeh M.
    Isr J Med Sci; 1989 Feb 09; 25(2):64-8. PubMed ID: 2703328
    [Abstract] [Full Text] [Related]

  • 15. Inosine monophosphate production is proportional to muscle force in vitro.
    Brooke MH, Choksi R, Kaiser KK.
    Neurology; 1986 Feb 09; 36(2):288-91. PubMed ID: 3945403
    [Abstract] [Full Text] [Related]

  • 16. ATP breakdown products in human skeletal muscle during prolonged exercise to exhaustion.
    Norman B, Sollevi A, Kaijser L, Jansson E.
    Clin Physiol; 1987 Dec 09; 7(6):503-10. PubMed ID: 3427883
    [Abstract] [Full Text] [Related]

  • 17. Muscle glycogen phosphorylase deficiency.
    Moses SW.
    Isr J Med Sci; 1989 Feb 09; 25(2):61-3. PubMed ID: 2703327
    [No Abstract] [Full Text] [Related]

  • 18. Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
    Kono N, Mineo I, Sumi S, Shimizu T, Kang J, Nonaka K, Tarui S.
    Neurology; 1984 Nov 09; 34(11):1471-6. PubMed ID: 6593602
    [Abstract] [Full Text] [Related]

  • 19. Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis.
    Hara N, Mineo I, Kono N, Kiyokawa H, Kawachi M, Yamada Y, Nakajima H, Shimizu T, Kuwajima M, Wang YL.
    Adv Exp Med Biol; 1989 Nov 09; 253A():381-6. PubMed ID: 2624217
    [No Abstract] [Full Text] [Related]

  • 20. [Glycogenosis (molecular mechanism of muscle glycogenosis)].
    Tarui S, Mineo I, Nakajima H, Kono N.
    Tanpakushitsu Kakusan Koso; 1988 Apr 09; 33(5):637-42. PubMed ID: 3270875
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.